Hisashi Umeoka - Taisho Pharmaceutical Director
Insider
Hisashi Umeoka is Director of Taisho Pharmaceutical Holdings
Phone | 81 3 3985 2020 |
Web | https://www.taisho-holdings.co.jp |
Taisho Pharmaceutical Management Efficiency
The company has return on total asset (ROA) of 0.0183 % which means that it generated a profit of $0.0183 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0345 %, meaning that it generated $0.0345 on every $100 dollars invested by stockholders. Taisho Pharmaceutical's management efficiency ratios could be used to measure how well Taisho Pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | INSIDER Age | ||
Marcela Kirberger | Elanco Animal Health | 57 | |
Karen Smith | Emergent Biosolutions | 52 | |
Gunupati BE | Dr Reddys Laboratories | 65 | |
Mukesh Rathi | Dr Reddys Laboratories | 45 | |
Scott Ferguson | Elanco Animal Health | 46 | |
Robert Sr | Emergent Biosolutions | 67 | |
Deepak MBA | Dr Reddys Laboratories | 50 | |
Joyce Lee | Elanco Animal Health | 47 | |
Jennifer Fox | Emergent Biosolutions | 51 | |
David Bayles | Viatris | N/A | |
Brian Roman | Viatris | 55 | |
Jonathan MD | Pacira BioSciences, | 50 | |
Lynn Kieffer | Emergent Biosolutions | N/A | |
Amy Landucci | Haleon plc | N/A | |
Dirk Ehle | Elanco Animal Health | 50 | |
Keith Katkin | Emergent Biosolutions | 48 | |
Roy MD | Pacira BioSciences, | 62 | |
Galia Inbar | Teva Pharma Industries | N/A | |
Amir Weiss | Teva Pharma Industries | 48 | |
MBA MBA | Dr Reddys Laboratories | 55 | |
Tamara Rogers | Haleon plc | 55 |
Management Performance
Return On Equity | 0.0345 | |||
Return On Asset | 0.0183 |
Taisho Pharmaceutical Leadership Team
Elected by the shareholders, the Taisho Pharmaceutical's board of directors comprises two types of representatives: Taisho Pharmaceutical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Taisho. The board's role is to monitor Taisho Pharmaceutical's management team and ensure that shareholders' interests are well served. Taisho Pharmaceutical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Taisho Pharmaceutical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Shigeru Uehara, Vice President and Presidentident of Subsidiary, Director | ||
Shinichi Tanaka, Gen Communications | ||
Akira Uehara, President Chairman of Subsidiary, Representative Director | ||
Jinsei Maruyama, Co Officer | ||
Tetsu Watanabe, Executive Director | ||
Jun Kuroda, Ex Director | ||
Ken Uehara, MD Director | ||
Hideki Iuchi, G Mang | ||
Hisashi Umeoka, Director |
Taisho Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Taisho Pharmaceutical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.0345 | |||
Return On Asset | 0.0183 | |||
Profit Margin | 0.08 % | |||
Operating Margin | 0.09 % | |||
Current Valuation | 1.27 B | |||
Shares Outstanding | 327.94 M | |||
Price To Earning | 20.67 X | |||
Price To Book | 0.57 X | |||
Price To Sales | 0.01 X | |||
Revenue | 268.2 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Consideration for investing in Taisho Pink Sheet
If you are still planning to invest in Taisho Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Taisho Pharmaceutical's history and understand the potential risks before investing.
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |